281 related articles for article (PubMed ID: 28578695)
21. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
[TBL] [Abstract][Full Text] [Related]
22. SIRT1 Mediates Neuroprotective and Neurorescue Effects of Camel α-Lactalbumin and Oleic Acid Complex on Rotenone-Induced Parkinson's Disease.
Ubaid S; Pandey S; Akhtar MS; Rumman M; Singh B; Mahdi AA
ACS Chem Neurosci; 2022 Apr; 13(8):1263-1272. PubMed ID: 35385250
[TBL] [Abstract][Full Text] [Related]
23. SIRT1 regulation modulates stroke outcome.
Petegnief V; Planas AM
Transl Stroke Res; 2013 Dec; 4(6):663-71. PubMed ID: 24323420
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of mir-132 induces dopaminergic neuronal death via activating SIRT1/P53 pathway.
Qazi TJ; Lu J; Duru L; Zhao J; Qing H
Neurosci Lett; 2021 Jan; 740():135465. PubMed ID: 33166640
[TBL] [Abstract][Full Text] [Related]
25. The epigenetic regulation of HIF-1α by SIRT1 in MPP(+) treated SH-SY5Y cells.
Dong SY; Guo YJ; Feng Y; Cui XX; Kuo SH; Liu T; Wu YC
Biochem Biophys Res Commun; 2016 Feb; 470(2):453-459. PubMed ID: 26768367
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin protects against rotenone-induced cytotoxicity: Involvement of mitophagy and the AMPK/SIRT1/PGC1α pathway.
Wang H; Dou S; Zhu J; Shao Z; Wang C; Xu X; Cheng B
Neuropeptides; 2021 Jun; 87():102134. PubMed ID: 33639357
[TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
[TBL] [Abstract][Full Text] [Related]
28. SIRT1 and SIRT2: emerging targets in neurodegeneration.
Donmez G; Outeiro TF
EMBO Mol Med; 2013 Mar; 5(3):344-52. PubMed ID: 23417962
[TBL] [Abstract][Full Text] [Related]
29. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.
Roberts RF; Wade-Martins R; Alegre-Abarrategui J
Brain; 2015 Jun; 138(Pt 6):1642-57. PubMed ID: 25732184
[TBL] [Abstract][Full Text] [Related]
30. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
Schulz-Schaeffer WJ
Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
[TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein, lipids and Parkinson's disease.
Ruipérez V; Darios F; Davletov B
Prog Lipid Res; 2010 Oct; 49(4):420-8. PubMed ID: 20580911
[TBL] [Abstract][Full Text] [Related]
32. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
33. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies.
Owen AD; Schapira AH; Jenner P; Marsden CD
J Neural Transm Suppl; 1997; 51():167-73. PubMed ID: 9470137
[TBL] [Abstract][Full Text] [Related]
34. 17β-Estradiol Modulates SIRT1 and Halts Oxidative Stress-Mediated Cognitive Impairment in a Male Aging Mouse Model.
Khan M; Ullah R; Rehman SU; Shah SA; Saeed K; Muhammad T; Park HY; Jo MH; Choe K; Rutten BPF; Kim MO
Cells; 2019 Aug; 8(8):. PubMed ID: 31430865
[TBL] [Abstract][Full Text] [Related]
35. Sesamin and sesamol attenuate H
Ruankham W; Suwanjang W; Wongchitrat P; Prachayasittikul V; Prachayasittikul S; Phopin K
Nutr Neurosci; 2021 Feb; 24(2):90-101. PubMed ID: 30929586
[No Abstract] [Full Text] [Related]
36. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
[TBL] [Abstract][Full Text] [Related]
37. Role of Sirt1 during the ageing process: relevance to protection of synapses in the brain.
Godoy JA; Zolezzi JM; Braidy N; Inestrosa NC
Mol Neurobiol; 2014 Dec; 50(3):744-56. PubMed ID: 24496572
[TBL] [Abstract][Full Text] [Related]
38. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
Norris EH; Giasson BI
Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
[TBL] [Abstract][Full Text] [Related]
39. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
[TBL] [Abstract][Full Text] [Related]
40. Modulation of alpha-synuclein aggregation by dopamine: a review.
Leong SL; Cappai R; Barnham KJ; Pham CL
Neurochem Res; 2009 Oct; 34(10):1838-46. PubMed ID: 19444607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
